Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer

Radiotherapy and Oncology

Volumn 81, Issue 3, 2006, Pages 264-268

  Bradley, Jeffrey D ^a   Nofal, Ahmed N ^a   El Naqa, Issam M ^a   Lu, Wei ^a   Liu, Jubei ^a   Hubenschmidt, James ^a   Low, Daniel A ^a   Drzymala, Robert E ^a   Khullar, Divya ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4D CT imaging; Helical; Lung cancer; Maximum intensity projection; Stereotactic body radiation therapy

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; AVERAGED INTENSITY; BREATHING MECHANICS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG CANCER; MAXIMUM INTENSITY PROJECTION; MULTIVARIATE ANALYSIS OF VARIANCE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; RANK SUM TEST; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL SIGNIFICANCE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TUMOR VOLUME;

HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RESPIRATION; RETROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845232182     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.10.009     Document Type: Article

References (14)

1. Keall P.J., Joshi S., Vedam S.S., et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 32 (2005) 942-951
2. Low D.A., Nystrom M., Kalinin E., et al. A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing. Med Phys 30 (2003) 1254-1263
3. Lu W., and Parikh P. Quantitation of the reconstruction quality of a four-dimensional computed tomography process for lung cancer patients. Med Phys 32 (2005) 890-901
4. Rietzel E., and Chen G. Four-dimensional image-based treatment planning: target volume segmentation and dose calculation in the presence of respiratory motion. Int J Radiat Oncol Biol Phys 61 (2005) 1535-1550
5. Underberg R., and Lagerwaard F. Use of maximum intensity projections (MIP) for target volume generation in 4D CT scans for lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 253-260
6. Deasy J., Blanco A., and Clark V. CERR: a computational environment for radiotherapy research. Med Phys 30 (2003) 979-985
7. McGarry R.C., Papiez L., Williams R., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
8. Onishi H., Nagata Y., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for patients with stage I non-small cell lung carcinoma: clinical outcomes in 241 cases of a Japanese multi-institutional study. Int J Radiat Oncol Biol Phys 57 (2003) S142
9. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
10. Song D.Y., Kavanaugh B.D., Benedict S.H., et al. Stereotactic body radiation therapy. Rationale techniques, applications, and optimization. Oncology (Williston Park) 18 (2004) 1419-1430
11. Blomgren H., Lax I., Nashlund I., et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34 (1995) 861-870
12. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
13. Wulf J., Baier K., Mueller G., et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
14. Timmerman R., McGarry R., Papiez L., et al. Initial report of a prospective phase I trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 62 (2005) S99